MedTrace Logo

Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition.

NCT00189059 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2005-09-16

No results posted yet for this study

Summary

The acute and subchronic effects of amitriptyline were compared to placebo in a double-blind crossover randomized study on driving ability and driving-related skills in chronic neuropathic pain patients.It was hypothesized that nocturnally administered 25 mg amitriptyline might affect driving performance negatively after acute, but not after subchronic treatment.

Conditions

  • Chronic Neuropathic Pain

Interventions

DRUG

amitriptyline

Sponsors & Collaborators

  • Utrecht University

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Edmund Volkerts, PhD · University of Utrecht, department of Psychopharmacology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2005-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00189059 on ClinicalTrials.gov